Resource Type

Journal Article 145

Year

2024 1

2023 10

2022 7

2021 10

2020 6

2019 4

2018 4

2017 7

2016 8

2015 11

2014 10

2013 8

2012 4

2011 2

2010 11

2009 15

2008 7

2007 10

2006 1

2004 2

open ︾

Keywords

hepatocellular carcinoma 23

nasopharyngeal carcinoma 6

Hepatocellular carcinoma 5

primary 4

prognosis 4

carcinoma 3

esophageal squamous cell carcinoma 3

metastasis 3

mutation 3

Chinese 2

E-cadherin 2

Epstein-Barr virus 2

Gut microbiota 2

biomarker 2

clinical 2

hepatocellular carcinoma (HCC) 2

immunotherapy 2

liver fibrosis 2

miRNA 2

open ︾

Search scope:

排序： Display mode:

Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a

Li Ma, Bin Wang, Yuanxiong Long, Hanmin Li

Frontiers of Medicine 2017, Volume 11, Issue 2,   Pages 191-202 doi: 10.1007/s11684-017-0512-0

Abstract:

Primary hepatic carcinoma (PHC) is a common malignant tumor in China.systematic review with meta-analysis aimed to assess the effect of TCM combined with Western therapy on primaryhepatic carcinoma.

Keywords： traditional Chinese medicine     primary hepatic carcinoma     meta-analysis    

HTML PDF Collect

A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy

Xiaolong Wei,Chunfa Chen,Didi Xi,Jinwen Bai,Wenhe Huang,Luoxiang Rong,Mingyao Wu,Guojun Zhang

Frontiers of Medicine 2015, Volume 9, Issue 1,   Pages 112-116 doi: 10.1007/s11684-014-0345-z

Abstract:

Primary neuroendocrine breast carcinoma (NEBC) is a very rare type of breast cancer.

Keywords： neuroendocrine carcinoma     neo-adjuvant therapy     breast    

HTML PDF Collect

Rapamycin enhances the anti-tumor activity of cabozantinib in cMet inhibitor-resistant hepatocellular carcinoma

Frontiers of Medicine 2022, Volume 16, Issue 3,   Pages 467-482 doi: 10.1007/s11684-021-0869-y

Abstract: endothelial growth factor receptor 2, is the second-line treatment for patients with advanced hepatocellular carcinomaIn this study, we found that cMet-low HCC cells showed primary resistance to cMet inhibitors, and the

Keywords： hepatocellular carcinoma     cabozantinib     primary resistance     rapamycin    

HTML PDF Collect

Adjuvant treatment strategy after curative resection for hepatocellular carcinoma

Wei Zhang, Bixiang Zhang, Xiao-ping Chen

Frontiers of Medicine 2021, Volume 15, Issue 2,   Pages 155-169 doi: 10.1007/s11684-021-0848-3

Abstract: Hepatic resection represents the first-line treatment for patients with resectable hepatocellular carcinomaAdjuvant hepatic artery infusion chemotherapy might be beneficial in patients with vascular invasion.

Keywords： hepatocellular carcinoma     adjuvant treatment     hepatic resection     recurrence    

HTML PDF Collect

Metformin and metabolic diseases: a focus on hepatic aspects

Juan Zheng,Shih-Lung Woo,Xiang Hu,Rachel Botchlett,Lulu Chen,Yuqing Huo,Chaodong Wu

Frontiers of Medicine 2015, Volume 9, Issue 2,   Pages 173-186 doi: 10.1007/s11684-015-0384-0

Abstract: As a drug that primarily targets the liver, metformin suppresses hepatic glucose production (HGP), servingAs supported by the results from both human and animal studies, metformin improves hepatic steatosisMechanistically, the beneficial effects of metformin on hepatic aspects are mediated through both adenosine

Keywords： metformin     diabetes     hepatic steatosis     inflammatory response     insulin resistance    

HTML PDF Collect

Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent

Ruoxi Zhang, Jing Chen, Diangang Liu, Yu Wang

Frontiers of Medicine 2019, Volume 13, Issue 3,   Pages 398-408 doi: 10.1007/s11684-019-0689-5

Abstract: receptor (UT) antagonist palosuran on rats with carbon tetrachloride (CCl )-induced cirrhosis, the hepaticfibrosis, the metalloproteinase-13 (MMP-13)/ tissue inhibitor of metalloproteinase-1 (TIMP-1) ratio, hepaticPrimary hepatic stellate cells (HSCs) are used to investigate the changes in UII/UT expression and thethat long-term administration of palosuran can decrease PP in cirrhosis, which results from decreased hepatic

Keywords： portal hypertension     cirrhosis     urotensin II     palosuran     hepatic stellate cell    

HTML PDF Collect

Beneficial effects of preventive cholecystectomy in patients with hepatic cancer

LIU Anzhong, LI Jun, HUA Huwei

Frontiers of Medicine 2008, Volume 2, Issue 2,   Pages 139-142 doi: 10.1007/s11684-008-0026-x

Abstract: is no conclusive answer to the question whether excising gall bladder is helpful to the patient with hepaticThe survival rate of patients with hepatic cancer for more than two years has been increased, and thestone are relatively higher among these patients, which may seriously complicate treatment of advanced hepaticfrom 2002 to 2006 to assess the clinical significance of preventive cholecystectomy in patients with hepaticOne hundred and eighteen cases of postoperative patients with hepatic cancer, who survived for more than
HTML PDF Collect

Paeoniflorin prevents hepatic fibrosis of by inhibiting TGF-β1 production from macrophages in mice

CHU Deyong, LI Conglei, SHEN Jilong, WU Qiang

Frontiers of Medicine 2008, Volume 2, Issue 2,   Pages 154-165 doi: 10.1007/s11684-008-0029-7

Abstract: In order to investigate the effect of paeoniflorin (PAE) on hepatic fibrosis of mice with and , a modelof hepatic fibrosis caused by schistosomiasis was established in mice infected with cercariae of .Hepatic granuloma and fibrosis were evaluated via HE and Masson staining. The expression of ?1 in optimum macrophage-conditioned medium (OPMCM) on the proliferation of hepatic stellate cells (HSCsIn a word, PAE can prevent hepatic granuloma and fibrosis caused by schistosomiasis japonica through

Keywords： cercariae     collagen     hyaluronic     OPMCM     soluble    

HTML PDF Collect

Influence of β-elemene on the secretion of angiotensin II and expression of AT1R in hepatic stellate

Ling YANG, Rui ZHU, Qingjing ZHU, Dan DAN, Jin YE, Keshu XU, Xiaohua HOU

Frontiers of Medicine 2009, Volume 3, Issue 1,   Pages 36-40 doi: 10.1007/s11684-009-0020-y

Abstract: the secretion of angiotensin II (ANG II) and the expression of angiotensin receptor type 1 (AT1R) in hepaticprotein expression of AT1R, which may be the mechanism by which β-elemene prevents the progress of hepatic

Keywords： liver cirrhosis     beta-elemene     hepatic stellate cells     angiotensin II     receptor     angiotensin     type 1    

HTML PDF Collect

Evaluation of power regeneration in primary suspension for a railway vehicle

Ruichen WANG, Zhiwei WANG

Frontiers of Mechanical Engineering 2020, Volume 15, Issue 2,   Pages 265-278 doi: 10.1007/s11465-019-0571-9

Abstract: rail vehicles, this study presents the feasibility of using power regenerating dampers (PRDs) in the primaryPRDs are configured as hydraulic electromagnetic-based railway primary vertical dampers and evaluatedof the generator, and the electromagnetic configuration provides a controllable damping force to the primaryIn several case studies, generic railway vehicle primary suspension systems that are configured to includeResults indicate that PRDs can simultaneously replace conventional primary vertical dampers, regenerate

Keywords： railway vehicle     primary damper     power regeneration     ride comfort     running safety    

HTML PDF Collect

Immunohistochemical characterization of hepatic stem cell-related cells in developing human liver

XU Jun, HU Yong, WANG Jian, ZHANG Taiping, ZHOU Ji, YU Hongyu

Frontiers of Medicine 2007, Volume 1, Issue 3,   Pages 264-268 doi: 10.1007/s11684-007-0050-2

Abstract: Little is known about the expression characteristics of the various kinds of possible markers in hepaticH-E staining and immunohistochemical methods were used to observe the expression of hepatic/cholangiocellularGST- was detected in hepatic cord cells from the sixth week and in the ductal plate cells from the eighthCK19 expression peaks during the 6th–11th weeks in hepatic cord cells and decreases gradually afterwardsAt 16 weeks’ gestation, most hepatic cord cells begin to differentiate into hepatocytes and abundant

Keywords： origin     Little     mesenchymal tissue     cords/mesenchymal tissue     CD34    

HTML PDF Collect

Optimized human factor IX expression cassettes for hepatic-directed gene therapy of hemophilia B

Ru Zhang,Qiang Wang,Lin Zhang,Saijuan Chen

Frontiers of Medicine 2015, Volume 9, Issue 1,   Pages 90-99 doi: 10.1007/s11684-015-0390-2

Abstract:

Gene therapy provides a potential cure for hemophilia B, and significant progress has been achieved in liver-directed gene transfer mediated by adeno-associated viral vectors. Recent clinical trials involving the use of a self-complementary adeno-associated virus serotype 8-human codon-optimized factor IX (AAV8-hFIXco) vector demonstrated encouraging efficacy with hFIX expression stabilized at 1% to 6% of normal level in patients, but safety concerns related to high vector doses are still present. Thus, further improvement of AAV vectors and hFIX expression cassette may positively contribute to the ultimate success of hemophilia B gene therapy. In this study, to obtain a higher expression level of hFIX that potentiates the coagulant capacity of recipients, human FIX expression vector was optimized by upgrading the codon adaption index and adjusting the GC content, inserting a Kozak sequence (GCCACC), and introducing a gain-of-function mutation, R338L (FIX Padua). The efficiency of the published and the presently constructed cassettes was compared through in vivo screening. In addition, the regulatory elements that control the FIX gene expression in these cassettes were screened for liver-specific effectiveness. Among all the constructed cassettes, scAAV-Pre-hFIXco-SIH-R338L, which was the construct under the control of the prothrombin enhancer and prealbumin promoter, resulted in the highest level of coagulant activity, and the expression levels of two constructed cassettes (scAAV-Chi-hFIXco-SIH-R338L and scAAV-Pre-hFIXco-SIH-R338L) were also higher than that of the published cassette (scAAV-LP1-hFIXco-SJ). In summary, our strategies led to a substantial increase in hFIX expression at the protein level or a remarkably elevated coagulant activity. Thus, these reconstructs of hFIX with AAV vector may potentially contribute to the creation of an efficacious gene therapy of hemophilia B.

Keywords： factor IX     hemophilia B     liver-specific regulatory elements     hydrodynamic gene transfer    

HTML PDF Collect

Dynein axonemal heavy chain 10 deficiency causes primary ciliary dyskinesia in humans and mice

Frontiers of Medicine   Pages 957-971 doi: 10.1007/s11684-023-0988-8

Abstract: Primary ciliary dyskinesia (PCD) is a congenital, motile ciliopathy with pleiotropic symptoms.

Keywords： DNAH10     mice     motile cilia     mutation     primary ciliary dyskinesia    

HTML PDF Collect

Knockdown of RFC4 inhibits the cell proliferation of nasopharyngeal carcinoma and

Frontiers of Medicine 2023, Volume 17, Issue 1,   Pages 132-142 doi: 10.1007/s11684-022-0938-x

Abstract: Nasopharyngeal carcinoma (NPC) is a malignant tumor that mainly occurs in East and Southeast Asia.

Keywords： nasopharyngeal carcinoma     WGCNA     RFC4     proliferation    

HTML PDF Collect

Expression of integrin in hepatic fibrosis and intervention of resveratrol

Jianye WU, Chuanyong GUO, Jun LIU, Xuanfu XUAN

Frontiers of Medicine 2009, Volume 3, Issue 1,   Pages 100-107 doi: 10.1007/s11684-009-0013-x

Abstract: The aim of this study was to explore the expression of integrin-β1 in different stages of hepatic fibrosisand intervention of resveratrol as well as the way by which integrin-β1 promoted hepatic fibrosis.Hepatic fibrosis models of male Sprague Dawley (SD) rats were created and intragastric administrationgrowth factor-β (TGF-β) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in different stages of hepaticas the development of hepatic fibrosis.

Keywords： liver fibrosis     integrin-β1     resveratrol     tumor growth factor-β     tissue inhibitor of metalloproteinase-1    

HTML PDF Collect

Title Author Date Type Operation

Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a

Li Ma, Bin Wang, Yuanxiong Long, Hanmin Li

Journal Article

A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy

Xiaolong Wei,Chunfa Chen,Didi Xi,Jinwen Bai,Wenhe Huang,Luoxiang Rong,Mingyao Wu,Guojun Zhang

Journal Article

Rapamycin enhances the anti-tumor activity of cabozantinib in cMet inhibitor-resistant hepatocellular carcinoma

Journal Article

Adjuvant treatment strategy after curative resection for hepatocellular carcinoma

Wei Zhang, Bixiang Zhang, Xiao-ping Chen

Journal Article

Metformin and metabolic diseases: a focus on hepatic aspects

Juan Zheng,Shih-Lung Woo,Xiang Hu,Rachel Botchlett,Lulu Chen,Yuqing Huo,Chaodong Wu

Journal Article

Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent

Ruoxi Zhang, Jing Chen, Diangang Liu, Yu Wang

Journal Article

Beneficial effects of preventive cholecystectomy in patients with hepatic cancer

LIU Anzhong, LI Jun, HUA Huwei

Journal Article

Paeoniflorin prevents hepatic fibrosis of by inhibiting TGF-β1 production from macrophages in mice

CHU Deyong, LI Conglei, SHEN Jilong, WU Qiang

Journal Article

Influence of β-elemene on the secretion of angiotensin II and expression of AT1R in hepatic stellate

Ling YANG, Rui ZHU, Qingjing ZHU, Dan DAN, Jin YE, Keshu XU, Xiaohua HOU

Journal Article

Evaluation of power regeneration in primary suspension for a railway vehicle

Ruichen WANG, Zhiwei WANG

Journal Article

Immunohistochemical characterization of hepatic stem cell-related cells in developing human liver

XU Jun, HU Yong, WANG Jian, ZHANG Taiping, ZHOU Ji, YU Hongyu

Journal Article

Optimized human factor IX expression cassettes for hepatic-directed gene therapy of hemophilia B

Ru Zhang,Qiang Wang,Lin Zhang,Saijuan Chen

Journal Article

Dynein axonemal heavy chain 10 deficiency causes primary ciliary dyskinesia in humans and mice

Journal Article

Knockdown of RFC4 inhibits the cell proliferation of nasopharyngeal carcinoma and

Journal Article

Expression of integrin in hepatic fibrosis and intervention of resveratrol

Jianye WU, Chuanyong GUO, Jun LIU, Xuanfu XUAN

Journal Article